glaucoma. GLAUCOMA
Conditions
Interventions
Intervention 1: Insertion of Ahmed valve in supra temporal area of eye and no injection of bevacizumab in the end of surgery. Intervention 2: Insertion of Ahmed valve in supra temporal area of eye and
Treatment - Drugs
Insertion of Ahmed valve in supra temporal area of eye and no injection of bevacizumab in the end of surgery
Insertion of Ahmed valve in supra temporal area of eye and injection of 2.5mg bevacizumab in subconjunctiva adjacent to Ahmed valve in the end of surgery
Sponsors
Iran University Of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: In this randomized clinical trial inclusion criteria are:1-age more than 18 with IOP>21 mmHg with maximal medications ;2- intolerance to medications ;3-history of previous cataract surgery or trabeculectomy with uncontrolled IOP ;4-low success of trabeculectomy due to conjunctival scar .Exclusion criteria are :1-patients with VA NLP; 2-indesirable informed consent ;3-patients who can not be present for follow up; 4-history of previous shunt surgery or CPC; 5-History of SB or Silicone in the eye ;6-Vitreous in AC which need VitX ;7-uveitis ;8- nanophthalmous; 9-struge weber or any disease with increased episcleral pressure ; 10-patients who need adjunct surgery in addition to shunt ;11 -NVG 12-pregnancy or lactating patients will be enrolled from Radoul Akram Hospital and Central eye clinic and the procedure will be done with same techniques by Dr.Miraftabi and Nilforoushan.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: Goldman applanation tonometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of glaucoma medications. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: quantitative.;Postoperative complications. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: qualitative. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezoo Miraftabi MD
Iran University of Medical Sciences
Outcome results
None listed